ADVERTISEMENT

From the Desk of the CEO

Community pharmacists are rewriting the rules of practice
James Keagy
/ Categories: CEO Blog

Community pharmacists are rewriting the rules of practice

Two independent pharmacists show how autonomy, transparency, and clinical care can restore joy—and sustainability—to community pharmacy

Over the past 3 years, I’ve spoken with many community pharmacists who are deeply dissatisfied with their work. The reasons are well known and don’t need repeating. What deserves more attention is what is working—and how those examples can help move our profession forward.

Recently, at the Pennsylvania Pharmacists Association meeting in Harrisburg, I met two community pharmacists who are experiencing something rarely discussed: professional fulfillment. Brandon Antinopoulos, PharmD, of Forward Rx Pharmacy and Kyle McCormick, PharmD, of Blueberry Pharmacy are building practices that look very different from the status quo—and their experiences offer a powerful lesson for the profession.

Starting with a simple goal: Serve patients without interference

Both pharmacists began with the same core motivation: a love for their communities and the patients they serve. They wanted to practice pharmacy without interference that distracted from patient care.

To do that, each adopted a cost-plus pharmacy model. They calculated the true cost of providing prescription medications, added a reasonable and transparent fee to ensure sustainability, and made that pricing public so patients could clearly understand the value being delivered. Insurance is accepted only when payers agree to those cost-plus terms.

The result? Predictability. Transparency. And control.

Predictable revenue, early profitability, and growing demand

The outcomes of this approach have been striking. I haven’t seen two pharmacists in a long time who were as calm, confident, and satisfied in their professional lives. One told me he became profitable very quickly after opening and no longer worries about when—or whether—he will be paid.

Both practices continue to grow month after month. One has established contracts with local employers to provide clinical services, while the other has built strong referral relationships with physicians in the community.

In each case, their business models don't compete with patient care—they enable it.

Practicing at the top of their training—and why it matters

These pharmacists are doing exactly what they were trained to do. Their practices are highly clinical. They intervene daily as medication therapy experts, ensuring appropriate therapy, and better outcomes—and they are paid directly for that work.

Rather than waiting for perfect conditions or system-wide reform, they defined their clinical services, set clear fees, and educated their communities about what they offer.

A major source of their professional fulfillment is control—over clinical decisions, time, and how patient needs are met. That autonomy has made a meaningful difference for both pharmacists and patients.

Many student pharmacists struggle with the tension between patient care and administrative burden. Some ultimately look outside direct care, even though caring for patients is what drew them to pharmacy in the first place.

What these two pharmacists demonstrate is that a full, rewarding career in direct patient care is already happening in communities across the country.

The path forward is already being built

Congratulations to Antinopoulos and McCormick for leading the way. Their work shows that community pharmacy does not need to abandon patient care to survive—it needs our collective encouragement to rethink how care is delivered and valued.

For every pharmacist. For all of pharmacy.

Previous Article APhA: Adding value to member’s lives
Next Article Lessons from Coach Lou Holtz
Print
5814
Please login or register to post comments.

Featured Post

Posted: Mar 10, 2026

Lessons from Coach Lou Holtz

APhA CEO Michael Hogue reflects on the wisdom of legendary football coach Lou Holt, while encouraging pharmacy professionals to consider how the coach’s words may impact their role in the profession.

All Posts

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Posted: Aug 12, 2026

Remembering pharmacy icon Peter Vlasses

On August 1, 2026, pharmacy lost another of our trailblazers, Peter Vlasses, former ACPE executive director. As I learned this news, I was reminded that Pete was the 2022 Remington Honor Medalist, earning the profession’s highest honor.

Posted: Aug 5, 2026

HRSA’s proposed 340B rebate pilot risks disrupting pharmacist-provided care

Pharmacists, regardless of practice setting, are well aware of the impact of the 340B program on pharmacy revenue. For student pharmacists and others who may not have encountered this program before, you can get a crash course on the history of the program from its origins in 1992 and how it currently operates at the Health Resources & Service Administration’s (HRSA’s) website.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Posted: Apr 30, 2026

Redefining Possible: A personal reflection on passion, purpose, and joy

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP, President, APhA

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement